Nayralis Pharma Private Limited
About Nayralis Pharma Private Limited
Data last updated:
Nayralis Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 15 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U70200MH2017PTC296214. Its GSTIN is 04AAECI5339R1Z3 (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It was formerly known as Indiacon Realty Ventures Private Limited. It is led by directors including Prajakta Ajay Karambe and Rahul Sharma.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at B – 605 Floor – 6 Ashok Complex Ranade Road Dadar (W), Mumbai, Maharashtra, India – 400028.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.06 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.91 Lakh (net margin -48.6%) and EBITDA of -₹3.91 Lakh (EBITDA margin -48.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nayralis Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 605 Floor – 6 Ashok Complex Ranade Road Dadar (W), Mumbai, Maharashtra, India – 400028
- IndustryReal Estate, Real Estate Leasing, Contractual Work
To see the full contact details of Nayralis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nayralis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nayralis Pharma Private Limited, buy the company report.
Financials of Nayralis Pharma Private Limited
FY 2022 filings availableNayralis Pharma Private Limited reported revenue of ₹8.06 Lakh (up 3816% YoY) for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹8.06 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -48.6% | ||||
| Net Profit Margin | -48.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nayralis Pharma Private Limited, buy the company report.
Board of directors of Nayralis Pharma Private Limited
Nayralis Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prajakta Ajay Karambe | Director | 04 Feb 2021 | 5 Years 8 Months | Current |
| Rahul Sharma | Director | 04 Feb 2021 | 5 Years 8 Months | Current |
| Sailee Vijay Kolhatkar | Director | 15 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Nayralis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambey Exim Private Limited | ₹8.06 Lakh (FY 2020) | -70.0% | Ahmedabad, Gujarat, India | |||
| Next Vision Research Solutions Private Limited | ₹8.06 Lakh (FY 2023) | 625.0% | New Delhi, Delhi, India | |||
| Mayudeep Private Limited | ₹8.06 Lakh (FY 2024) | 280.0% | Pune, Maharashtra, India | |||
| Aadhanya International Private Limited | ₹8.06 Lakh (FY 2020) | Salem, Tamil Nadu, India | ||||
| Dreaming Agro Farms & Biotech Private Limited | ₹8.06 Lakh (FY 2025) | -70.0% | Bareilly, Uttar Pradesh, India | |||
| Nayralis Pharma Private Limitedthis company | ₹8.06 Lakh (FY 2022) | -₹3.91 Lakh | -48.6% | 3816.0% | Mumbai, Maharashtra, India | |
| Trapezium Commerce Private Limited | ₹8.05 Lakh (FY 2024) | -74.0% | Jodhpur, Rajasthan, India | |||
| Glad Publications Private Limited | ₹8.05 Lakh (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| LHN Traders Private Limited | ₹8.05 Lakh (FY 2024) | -45.0% | Patna, Bihar, India | |||
| Optima Stainless Private Limited | ₹8.05 Lakh (FY 2016) | -96.0% | Mumbai, Maharashtra, India | |||
| Ratnavali Agro Food Private Limited | ₹8.05 Lakh (FY 2024) | -89.0% | Hanumangarh, Rajasthan, India |
To see the full peer comparison of Nayralis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nayralis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nayralis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nayralis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECI5339R1Z3 | Chandigarh | Active | 12 Jan 2021 |
To see the full GST registrations and return filing status of Nayralis Pharma Private Limited, buy the company report.
Recent activity
Nayralis Pharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Abhilash ceased to be Director on 05 Feb 2021.
Frequently asked questions
Nayralis Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 15 June 2017 (9+ years old) and is registered under CIN U70200MH2017PTC296214.
Nayralis Pharma has 3 current directors:
- Prajakta Ajay Karambe - Director
- Rahul Sharma - Director
- Sailee Vijay Kolhatkar - Director
The latest financial statements of Nayralis Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Nayralis Pharma is 04AAECI5339R1Z3, registered in Chandigarh.
The CIN (Corporate Identification Number) of Nayralis Pharma is U70200MH2017PTC296214. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nayralis Pharma was incorporated on 15 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nayralis Pharma by revenue are Ambey Exim Private Limited, Next Vision Research Solutions Private Limited, Mayudeep Private Limited, Aadhanya International Private Limited, Dreaming Agro Farms & Biotech Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Abhilash ceased to be Director on 05 Feb 2021. Prajakta Ajay Karambe was appointed as Director on 04 Feb 2021. Rahul Sharma was appointed as Director on 04 Feb 2021. Nayralis Pharma has 4 board changes on record in total.
The registered office of Nayralis Pharma is at B – 605 Floor – 6 Ashok Complex Ranade Road Dadar W, Mumbai, Maharashtra, India – 400028.
Nayralis Pharma operates in the real estate industry, in the real estate leasing segment.
The compliance status of Nayralis Pharma is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.